A new experimental approach was designed to measure regional rate constants for [18Fl2-fluoro-2-D deoxyglucose in the three-compartment modeL A pro grammed infusion was used to keep the plasma tracer concentration constant for the first 20 min, Positron emis sion tomography images of the brain were taken every minute for 20 min in a low-resolution mode, then every 15-20 min for 2-3 h in a medium-resolution mode. Two simplified operational equations for the calculation of the regional rate constants were derived that incorporated the contribution of the vascular compartment to tissue ac tivity. The first equation was applied to data collected during the initial 20 min (when the concentration of plasma tracer was constant) to estimate the values of kj ,
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/0.,11, and the fraction of the vascular compartment. The second equation was applied to data collected during the whole experimental period to find the value of KS and to provide a better estimate of 11. The regional rate con stants measured experimentally in three dogs and a brain tumor patient agreed well with those in the literature. This method permits estimation of the local CMRglu under pathological conditions using regionally measured rate constants and provides new information on the pathophysiological meaning of the rate constants. Key Words: Compartment modcl-2-Fluorodeoxyglucose Local cerebral glucose utilization-Positron emission to mography-Programmed infusion-Regional rate con stants.
The rate constants for FDG or [IIC]2-deoxyglu cose (DG) in the human brain have usually been measured by determining the time course of the plasma concentration (C � ) and the tissue concentra tion (A f) of a tracer following its administration as an intravenous bolus. A nonlinear least-squares method is then applied to the operational equation of Sokoloff et al. (1977) or Phelps et al. (1979) , which describes the relationship between q and Ai Reivich et al. , 1982) . However, a bolus injection produces a sharp peak in the initial part of the C � curve. This results in inaccuracies in the C � measurement Kato et aI. , 1984) , a significant contribution of the vascular compartment to Ai [which can be >10% during the first 5 min ], and a considerable backflux of the tracer (Gjedde, 1982) . These errors, combined with the limitations of positron emission tomography (PET), result in additional inaccuracy in the initial part of the Ai curve.
To avoid some of these difficulties and to increase the accuracy of the measurement of rate constants, we propose a method that keeps C � constant for an FIG. 1. The three-compartment model for the measurement of local CMRglu from Phelps et aL (1979) . See the text for description of the variables and constants.
initial 20-min period by means of a programmed in fusion. We also describe the derivation of two sim plified operational equations used in the calculation of the rate constants, reflecting the changes in the input function (C;). This method was used on dogs and a brain tumor patient.
THEORY
The differential equations describing the FDG three-compartment model as derived by (Fig. 1 ) are the following: C:' = kj C; -(k� + Iq)C: + ""4 C:i, (1) C:i,' = Iq c: -14 C:i,
where C;, C:, and C:i, are the tracer concentrations in the plasma, precursor, and metabolite pools in the brain, respectively, expressed as a function of time (t), C:' denotes dC:(t)dt, and kj to 14 are the rate constants for FDG. Then the actual tissue ac tivity (A f) measured by PET can be expressed as
where CBV is the fractional blood volume in the brain tissue. It was assumed that the plasma and whole brain concentrations of the tracer were the same. Strictly speaking, they are slightly ditferent (Phelps et aI., 1979) . q is defined as the sum of c: and C:i, to maintain compatibility with Phelps et al. (1979) . Taking the derivative of the tissue activity, q, with respect to time, substituting C:' and C:i,' from Eqs. 1 and 2, and rearranging for C:' we have:
After substituting c: = q -C:i, into Eq. 2, the solution for C:i, is
where (29 denotes the convolution integral. Substi tuting c: and C:i, from Eqs. 4 and 5, respectively, into q and defining f as the remainder between the calculated and measured tissue tracer concentra tions, the expression for f is Vol. 4, No.4, 1984 ktC -Cl"
describes the relationship between q and C; and is an alternative expression to that de rived by Phelps et al. (1979) . This equation is de signed to suit the calculation of the rate constants by a least-squares method, because all rate con stants except Iq appear only once. This simplifies analytical expressions for the partial derivatives with respect to those constants needed in a least squares fit.
During the period from 0 to 20 min when C; is kept constant (C;o) and C:i, is small, the influence of 14 is also small (Phelps et aI., 1979; Reivich et aI., 1982) . U sing the approximation of ""4 = 0 in Eq. 6 and substituting q into Eq. 3 gives
(8)
Expressions for the rate constants and fraction of blood volume are given as
Having measured C; and At during the experi ment, the rate constants were calculated as follows. Equation 7 was fitted to the initial 20 min of the tissue activity curve, and kj, 10., Iq, and CBV were calculated. The value of Iq obtained from fitting Eq. 7 is a combination of true Iq and 14 (14 influences the Iq value calculated from this set of data). Using the CBV value, At was transformed to q (see Eq.
3). After substituting kj and 10. into Eq. 6, the equa tion was fitted to the entire period of the tissue ac tivity curve, ct, to obtain the 14 value and a better estimate for Iq.
METHODS

Tracers
FDG was prepared in the MNI Medical Cyclotron Unit by a method previously described (Diksic and Jolly, 1983) . The radiochemical purity and specific activity as determined by HPLC were found to be >98% and >680 mCi/mmol, respectively. The animals and the patient were injected with 8-10 mCi of FDG. [14C]DG (specific activity 45-55 mCi/mmol; NEN) was used to determine the infusion schedule in the dogs.
Animal study
Preparation. Three young adult dogs weighing 18-22 kg were used in this study. The dogs were fasted over night. Anesthesia was induced by a single intramuscular injection of pentobarbital (10 mg/kg). During the experi mental period, the dogs were kept under light halothane anesthesia (0.5-0.8%) by means of a respirator (Mark 7; Bird). Catheters were inserted in a femoral artery and vein for blood sampling and for administration of the tracer and the saline infusion. The dogs were strapped onto the PET scanner couch with a heating blanket un derneath to keep them warm. Arterial blood pressure, heart rate, and rectal temperature were continuously monitored. Arterial blood gases were also monitored pe riodically. The following mean values (± SD) were mea sured: arterial blood pressure 132 ± 7 mm Hg; heart rate 112 ± 10 beats min-I; rectal temperature 37.7 ± 0.2°C; P0 2 96.3 ± 3.9 mm Hg; Peo 2 34.0 ± 5.9 mm Hg; pH 7.366 ± 0.063.
Determination of infusion schedule. An infusion schedule that maintained � constant from t = 0 to t = 20 min was determined by the method described by Patlak and Pettigrew (1976 was approximated as a sum of exponentials (Patlak and Pettigrew, 1976) .
The infusion schedule [lU)] was calculated as
The symbols in Eq. 15 were given in the work of Patlak and Pettigrew (1976) . 8(t) is the Dirac delta function rep resenting a bolus injection of the tracer at t = 0, and C is a constant adjusted to the total volume of the tracer solution.
To obtain the infusion schedule in the dogs, 100 /-LCi of [14C]DG was injected as a bolus into the femoral vein. Arterial blood samples were initially taken every 15-30 s, with intervals increasing gradually up to 25 min. The time course of the plasma DG activity was fitted to the sum of two or three exponential curves with the CLSQ program (Cumming, 1962) to obtain the pulse response function. Since FDG and DG exhibit similar biological behavior (Miller and Kiney, 1981) , we felt that using the pulse response function obtained with DG for a deter mination of the infusion schedule was justified. This con clusion was confirmed in experiments where the infusion schedule derived from DG produced a constant plasma curve (Fig. 2) .
A computer-controlled infusion system was developed to allow automatic infusion of FDG according to the in fusion schedule. Our system consists of a commercial syringe pump (Model 355; Sage Instruments) and micro computer (MZ-80B; Sharp). The system was calibrated to obtain a linear relationship between input signal and infusion speed.
Scanning. The dogs were placed in a PET scanner (Therascan 3128) (Cooke et aI., 1984) and positioned with Time (min) the brain centered in the aperture to minimize nonuniform resolution effects (Hoffman et aI., 1982) . All scanning was performed at this fixed position, and only direct slices were used in our analysis. At appropriate time intervals after the tracer administration, blood samples were taken for plasma radioassay and glucose measurements. To tal blood loss during the entire experiment was estimated to be 25-30 m!. The tracer (8-10 mCi of FDG) was admin istered by infusion through the venous catheter during the initial 20 min. To bring the plasma concentration to a constant level, at t = 0 a calculated dose of the tracer was injected as a bolus simulating let). Scanning was started at t = 0, and images were taken every minute in a low-resolution mode [full width at half-maximum (FWHM) of 19.5 mm] during the first 20 min (first stage) and every 20 min in a medium-resolution mode (FWHM = 12.4 mm) during the subsequent 230 min (second stage). For both scanning modes, the axial resolution was FWHM = 12 mm.
Human study
Clinical history. A brain tumor patient was included in this experimental protocol. The patient was a 78-year-old male who had been healthy until autumn 1983 when he developed speech and gait disturbance. On the basis of computed tomography (CT) scans, the patient was diagnosed as having a left temporoparietal glioblastoma and was given steroid therapy (prednisolone 5 mg/day), which improved his condition. The major neurological symp toms at the time of the PET scan (5 months af ter the initial symptoms) were right-sided hemiplegia and expressive dysphasia. The patient died 15 days after the study. The diagnosis of glioblastoma was confirmed at autopsy.
Preparation and scanning procedure. Before the study, the patient was fasted overnight. A 23-gauge venous cath eter was placed in the vein of the left hand, which had been heated to 42°C in a water glove box to arterialize venous blood. The infusion schedule for the FDG was determined from the plasma clearance curve obtained by the injection of 100 f..l Ci of FDG as a bolus 2 h before the scan. The plasma samples were radioassayed by a liquid scintillation counter. A polyethylene tube (PE-90/S 36 in; Clay-Adams) was inserted into a vein of the right arm for the programmed infusion of FDG. The patient was placed in the PET scanner in a position that, on the basis of his CT scans, ensured scans through the tumor. The scanning and tracer administration (8 mCi of FDG) were similar to those described for animal experiments. In the second stage from 30 to 150 min, the images were taken every 15 min in a medium-resolution mode. Mean plasma sugar concentration during this study was 138 mg/dl. All pro cedures were performed under informed consent, and ap proved by the MNI Ethics Committee.
Data analysis
The actual tissue activity was calculated for circular and irregular regions of interest and displayed on the
screen as a function of time using program PDS (Thompson, 1983) . Different region-of-interest sizes were used: 0.4-11. 7 cm 2 for the dogs, and 1.6-110 cm 2 for the patient. A nonlinear least-squares method (Simon, 1972) was used to fit data obtained from the regions of interest. Only data from regions of interest larger than 1.6 cm 2 are reported here. The tissue activity values obtained from low-resolution images were corrected by relative re covery coefficient values (Hoffman et aI., 1979) to allow scans taken in a low-resolution mode to be compared with those taken in a medium-resolution mode. The correction factors (0.9-1.3) were determined for each region of in terest by reconstructing raw data obtained in a medium resolution mode as a low-resolution image. Convergence was obtained in all least-squares fits, except when fitting the values from a part of the peritumoral area and the center of the tumor where tracer accumulation was very low. For purposes of comparison, the metabolic rates rather than LCMRglu were estimated, as suggested by Hawkins et a!. (1981) , because the lumped constant might vary in a pathological condition. (Strictly speaking, the metabolic rates represent rates of phosphorylation: M, steady-state; f..l , non-steady-state formulation.) where kj lq
Equation 17 is derived from the operational equation of Phelps et al. (1979) by setting the ratio between plasma glucose concentration (C p ) and the lumped constant equal to 1 (see Hawkins et aI., 1981) . The ratio was used in this form to simplify comparison with the Hawkins et a!. data (1981) . In Ta ble 3, f..l NP' f..l NB' and f..l NH are the metabolic rates calculated with normal rate constants using the op erational equations from Phelps et al. (1979) , Brooks (1982) , and Hutchins et al. (1984) , respectively. In these equations, the ratio of the plasma glucose concentration and lumped constant was set to equal 1, again for easier comparison. f..l RP is the metabolic rate calculated with re gional rate constants using Eq. 17. Figure 2 shows a typical example of experimen tally measured Af and C � , calculated q and C�, and the vascular compartment (CBV . C � ), obtained from one of the dog studies. In all studies, C � reached the plateau level within 1 min and stayed at a constant level for 20 min (± 3%). The dog studies showed that C � during the first 5 min was higher ( + 5%) than the average of the measured C;
RESULTS
values over the first 20 min (Cr o ) , suggesting an error propagated by the use of [ 4 C]DG instead of FDG in the determination of the infusion schedule. After the tracer infusion was finished, a rapid de crease in the C; was observed, which could be fitted by the sum of two or three exponential curves. The C� curve showed a very rapid buildup, reaching 90% of the plateau level between 5 and to min. (The time required for 90% of the plateau level to be reached was dependent on the regional kj, J...'� , and tq values.) After 20 min, q decreased exponen tially. The slope of C:i, from 12 to 20 min appears to follow that of Ai, with the value of C:i, ap proaching that of Ai at a later stage. The calculated fraction of the vascular compartment in the Ai was 10-30% in the first few minutes (t = 1-5 min) and then rapidly decreased to 5 -10% at the end of the first stage (t = 20 min). In the second stage, the contribution from the vascular compartment was negligible «2%).
The measured rate constants for FDG averaged from the three dog brains and the brain tumor pa tient are given in Ta ble I. The rate constants pre viously published for normal adults (Phelps et aI. , 1979) and for the contralateral brain of ischemia pa tients (Hawkins et aI., 1981) are given for compar ison. The rate constants for either DG or FDG have not previously been measured in the adult dog brain. Our values appear similar to those measured with FDG in the normal human gray matter (Phelps et aI., 1979) and to those measured with DG in the normal rat gray matter (Sokoloff et al. , 1977) .
The rate constants obtained for the contralateral gray matter of the brain tumor patient were com patible with those of the ischemia patients of Hawkins et al. (1981) . However, kj, 10., and k'4 were higher and kj was lower than those reported for ischemia patients. Given the diabetic condition of this patient, the higher 10. value suggests that the brain acts to maintain a steady glucose concentra tion by balancing the higher pressure of glucose in flux (the plasma glucose level was 138 mg/dl) to the precursor pool by increasing the efflux rate (10.). The higher k'4 supports the prediction by that k'4 would become larger in a hypo metabolic state, implying a larger amount of glu cose-phosphate dephosphorylation. The value of k! is similar to that found in normal adults. The rate constants in the contralateral white matter were similar to those published by others (Table 1) . The rate constants in the brain tumor tissue showed sig nificant regional differences, but on average showed higher k! and lower k'4 values than those of the con tralateral gray matter.
Metabolic rates for the brain tumor patient in the contralateral gray and white matter, as calculated with Eq. 16, were lower than those in the ischemia patients (row 7 in Ta ble 1). However, calculated LCMRglu values were similar when the lumped constant obtained in normal adults was used (=30 f.Lmollmin/IOO g). The metabolic rates in the tumor tissue were also similar to those of the contralateral gray matter in spite of higher 1 8 F accumulation. The fraction of the vascular space in the tumor patient, calculated with Eq. 14, agreed with that determined by the [llC]CO study performed the following day (Table 1) .
To compare the effect on the calculated metabolic rates with the regionally measured rate constants and the set of rate constants measured in normal adults , we evaluated four re gions of interest in the patient brain (Fig. 3) . With the rate constants (Table 2) , the metabolic rates M R (subscript R refers to the use of regional rate con stants) and fL R P in Ta ble 3 were calculated for dif ferent experimental times using Eqs. 16 and 17. fLNP' fLNB' and fLNH represent the metabolic rates calculated with different operational equations as explained earlier. Since the most accurate estimate of the metabolic rate is obtained by using Eq. 6, as Hawkins et al. (1981) suggested, we used M R as a standard value and calculated deviations from it for the other metabolic rates (fL R P' fLNP' fLNB' fLNH in Ta ble 3). Metabolic values obtained with the normal set of rate constants were variable, with a maximum underestimation of 57% and a maximum overesti mation of 44%. Metabolic values calculated with the regional rate constants had a maximum under-
3. An image from the brain tumor patient at the level of 5 cm above orbitomeatal plane taken 35 min after the injec tion of [18Fj2-fluoro-2-D-deoxyglucose (FDG). A ring-shaped accumUlation of FDG is observed in the left temporoparietal area. The rate constants given in Table 2 were calculated for the region-of-interest areas labeled a to d. Vol. 4, No.4, 1984 estimation of 6% and a maximum overestimation of 6%.
DISCUSSION
Recent progress in the measurement of in vivo biochemical functions with PET is based on the physiologic modeling of tracer kinetics. The rate constants connecting physiological compartments in a model are essential for quantitative evaluation of the physiological parameters. However, these rate constants are seldom measured because of the difficulty involved.
We propose a method for the regional measure ment of the rate constants for FDG that uses a pro grammed infusion technique to keep the input func tion (C � ) constant. This allows us to use a simplified operational equation. The regionally determined rate constapts agree with those measured by others ( Table 1) . Our calculated metabolic rates are inde pendent of sampling time because of the use of re gional rate constants (see Ta ble 3 for comparison).
The accuracy of the measured rate constants is affected by the quantification capability of the PET machine used. In this study, care was taken to min imize the effects of nonuniform resolution, calibra tion errors, "(-ray attenuation, scattered and random coincidence events, dead time, and the variation in detector efficiency (Cooke and Evans, 1983) . The main sources of uncertainty were considered to be partial volume and recovery coefficient effects (Mazziotta et aJ., 1981) , which are a function of the machine's resolution, the object size, and the object shape. All these factors interact to compromise quantitation, especially for small structures (Hoffman et aI., 1979; Mazziotta et al., 1981 , Strother et aI., 1984 .
The equations used in our model were chosen in such a way as to minimize these errors. If a true AT is a product of a constant correction factor (Cr) and measured A T, the Cf will be induded in Eq. 7, which is derived by keeping C � constant, Then, 3) using regional (see Table 2 ) and normal rate constants in diff erent operational equations MR, metabolic rate calculated with the regional rate constants in Eq. 16; f-L R P and f-LNP' metabolic rates calculated using Eq. 17 with regional and normal rate constants, respectively ; f-LNB and f-LN H' metabolic rates calculated with normal rate constants from Brooks (1982) and Hutchins et al. (1984) , respectively. setting the ratio of the plasma glucose concentration and the lumped constant equal to I. The terminal slope was calculated by the terminal slope method (see Discussion). Deviations from MR expressed as percentages are shown in parentheses.
true At = CfbJ + Cfb2 + Cfh3c-k t (19) Since the rate constants are calculated with Eqs. 11-13, Cf is canceled out in deriving tq and 11. Sim ilarly, Eq. 6 becomes (20) When fitting data to Eq. 20, the influence of the early part of the curve (C � /Cf large) could be re duced by using the weighted nonlinear least-squares method. This would allow more accurate estimates of tq to tq to be obtained. The value of kj is directly influenced by Cf as well as by the changes in the vascular compartment. The correction for the vas cular compartment and the Cf factor, which was introduced to match images of the first and second stages, may be responsible for our relatively large kj (Table 1) . The correction made for the contri bution of the vascular compartment might contain a systematic error because the C� curve was deter-mined by sampling arterialized venous blood. This might not be equal to the capillary plasma concen tration because of a large extraction of FDG into the tissue in the first few seconds (Gjedde, 1982) . This phenomenon would be obscured, however, because the scan interval in our experiments was I min.
The study reported here demonstrates large vari ations in the estimated metabolic rates (strictly speaking, phosphorylation rates) when different sets of rate constants are used ( Table 3 ). The vari ation depends on the model used; it is usually an underestimation of 10-50% (Table 3) . These find ings agree with those in the literature (Hawkins et aI., 1981; Graham et aI., 1983; Wienhard et aI., 1983) .
As seen from Table 3 , different approximations of the operational equation lead to quite different glucose utilization estimates in various conditions. For example, the operational equation for LCMRglu of Phelps et al. (1979) , using a single image of the tracer concentration in the tissue at time T, can be simplified as
where Sc is a scaling factor varying with the lumped constant and q(n is an offset for Cf(n. In a hy pometabolic condition, Cf(n is small and close to qeD, which is calculated from C � and the rate con stants. The use of the normal rate constants results in a higher calculated Cb(n than the true value for the tissue under investigation, and can give even negative LCMRglu values, as has been reported by Hawkins et al. (1981) . Similar effects would explain the discrepancies in the metabolic rates estimated by using normal rate constants instead of regional rate constants in the Brooks (1982) and Hutchins et al. (1984) operational equations. Since we do not know the real values of the rate constants in the pathophysiological condition being studied, we need a means to establish them; accordingly we de veloped the technique described in this article. The results given in Table 3 show that the metabolic rates obtained by using regional rate constants are independent of sampling time.
The method described here, which keeps the plasma concentration constant, can estimate the net phosphorylation rate (called "metabolic rate" in th . is report) by another method, as suggested by GJedde (1982) . Assuming k'4 = 0 and CBV = 0, the asymptote of the Af curve during the first stage is equal to the product of the net FDG phosphoryla tion rate and qo (Eq. 7), with the intercept on the vertical axis representing the offset for unphos phorylated FDG. Plotting the quotient of A"'and C* f .
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as a unctIOn of time, the terminal slope of the curve will represent the net phosphorylation rate (Fig. 2 , inset). As expected (and shown in Ta ble 3), the ter minal slope method agrees well with the data cal culated with the regional rate constants. This pro cedure would be useful in institutions that intend to use the metabolic rate on a more routine basis. However, it must be realized that the 20-min period used in this work might not give accurate terminal slopes in some pathological conditions. The lumped constant is also an essential term in LCMRglu calculations and changes as a function of the rate constants (Sokoloff et aI., 1977) . Phelps et ai. (1983) recently proposed an alternative method to estimate the regional stability of the lumped con stant (LC):
Although the term q/p has not been measured for the human brain, the ratio for rat brain is given by Phelps et al. (1983) . We calculated the lumped con stant stability factor in the contralateral gray matter of the tumor patient using Eq. 22. A stability factor of 1. 31 was found, which is similar to that of normal adults (1.68 ± 0.35) (Phelps et aI., 1983 ). The regional rate constants of the glioblastoma showed large differences between the medial and lateral parts. The medial part of the tumor had lower kj, k�, and k'4 values, higher metabolic rate, and larger CBV (Table 1) . These findings are con sistent with those of Graham et al. (1983) and might be correlated with the pathophysiological behavior of the brain tumor, since the rate constants could reflect the true physical characteristics of the glu cose transport and metabolic machinery (Gjedde, 1984) .
A better estimate of LCMRglu using regional rate constants could be achieved by using a tracer with a shorter half-life such as [IIC]DG (MacGregor et aI., 1981) , because two to three times as much IIC tracer can be administered to the patient (Christman, 1981; Reivich et aI. , 1982) .
[IIC]DG would also give us better statistics during the first stage of the experiment. The use of the Sokoloff et al. equation (1977) for the calculation of LCMRglu would eliminate the need for the second stage of our protocol. Since the first stage provides values of kj, 10, and "1 with a contribution from k'S, the use of the Sokoloff et al. equation would give us good estimates of LCMRglu. With this procedure, data collection can be completed within 30 min.
There is no particular reason for choosing 20 min as the time of constant infusion. The purpose of the first stage is to measure kj, 10, and kj, because it is ?ifficult to measure them separately after q equil Ibrates. The simulation data using our regional rate constants showed that q approached the plateau within 5-15 min if C � was maintained constant. The initial shape of the A f curve is determined mainly by kj and 10, whereas the shape of the later stage is determined by kj, 10, and tq.
.
If this method is widely applied, it may be pos Sible to standardize the infusion schedule. The in fusion schedule was determined from the shape of the plasma curve following a bolus injection of the tracer. From compartment analysis of the plasma curves (t = 0-30 min) of normal controls performed as part of another protocol, we found that there are at least two types, as reported earlier by . The first type of curve is best fitted by the sum of three exponentials (averaged half-lives of t l = 0.239, t2 = 2.83, and l3 = 108. 0 min). The second type of curve is best fitted by the sum of two exponentials (ll = 1.80 and t2 = 30.8 min).
Using these data, it may be possible to develop sev eral predefined infusion schedules that can be se lected according to known clinical data.
Our protocol was designed to fulfill two objec tives. The first was to develop a method to measure reliably regional rate constants in the brain with the ultimate intention of investigating their pathophys iological meaning. The second objective was to cal culate LCMRglu using the true regional rate con stants. Our programmed infusion protocol demon strates the possibility of completing a DO study within 30 min.
